Antonetta Axup Chem430 F16 - Revision history

Aaxup: /* Enter Project Title here */

2016-09-28T14:18:42Z

Enter Project Title here

Aaxup: /* References (2 minimum) */

2016-09-28T14:18:05Z

References (2 minimum)

Aaxup: /* References (2 minimum) */

2016-09-28T14:17:30Z

References (2 minimum)

Aaxup: /* Instruments to be used */

2016-09-28T14:15:51Z

Instruments to be used

Aaxup: /* Proposal */

2016-09-28T14:15:05Z

Proposal

Aaxup: Created page with "Chemistry/Biochemistry Research 430 :Fall 2016 :Antonetta Axup :Junior Biochemistry Major ==Research Times== T/Thur 2-4 pm : section 01 = 0.25 credit = 4 hours per week. : se..."

2016-08-28T16:06:08Z

Created page with "Chemistry/Biochemistry Research 430 :Fall 2016 :Antonetta Axup :Junior Biochemistry Major ==Research Times== T/Thur 2-4 pm : section 01 = 0.25 credit = 4 hours per week. : se..."

New page

Chemistry/Biochemistry Research 430
:Fall 2016
:Antonetta Axup
:Junior Biochemistry Major

==Research Times==
T/Thur 2-4 pm
: section 01 = 0.25 credit = 4 hours per week.
: section 02 = 0.50 credit = 8 hours per week.

==Proposed Research Project==
===Enter Project Title here===

===General Information===
:Advisor: Audra Sostarecz
:Other research student collaborators: here
:Other Research Collaborators: here

===Proposal===

===Instruments to be used===

===References (2 minimum)===

===Research pledge===
I, Antonetta Axup, have read the Chem/Bioc 430 course syllabus and understand the general structure and expectations of the research program. The above material was prepared after consultation, and in conjunction with my research advisor.

@@ Line 24: / Line 24: @@
 ===References (2 minimum)===
-"Antibiotic / Antimicrobial Resistance." Centers for Disease Control and Prevention. Centers for Disease Control and 	Prevention, 02 Mar. 2016. Web. 19 Apr. 2016. <http://www.cdc.gov/drugresistance/>.
+:"Antibiotic / Antimicrobial Resistance." Centers for Disease Control and Prevention. Centers for Disease Control and 	Prevention, 02 Mar. 2016. Web. 19 Apr. 2016. <http://www.cdc.gov/drugresistance/>.
-Boire NA, Riedel S, Parrish NM (2013) Essential Oils and Future Antibiotics: New Weapons against Emerging ‘Superbugs’? J Anc Dis Prev Rem 1:105
+:Boire NA, Riedel S, Parrish NM (2013) Essential Oils and Future Antibiotics: New Weapons against Emerging ‘Superbugs’? J Anc Dis Prev Rem 1:105
-Nazzaro, Filomena, Florinda Fratianni, Laura De Martino, Raffaele Coppola, and Vincenzo De Feo. "Effect of Essential Oils on Pathogenic Bacteria."Pharmaceuticals 6.12 (2013): 1451-474. Web.
+:Nazzaro, Filomena, Florinda Fratianni, Laura De Martino, Raffaele Coppola, and Vincenzo De Feo. "Effect of Essential Oils on Pathogenic Bacteria."Pharmaceuticals 6.12 (2013): 1451-474. Web.
 ===Research pledge===
 I, Antonetta Axup, have read the Chem/Bioc 430 course syllabus and understand the general structure and expectations of the research program. The above material was prepared after consultation, and in conjunction with my research advisor.

← Older revision		Revision as of 14:15, 28 September 2016
Line 21:		Line 21:

	===Instruments to be used===		===Instruments to be used===
		+	Langmuir Monolayer Trough

	===References (2 minimum)===		===References (2 minimum)===

← Older revision		Revision as of 14:15, 28 September 2016
Line 18:		Line 18:

	===Proposal===		===Proposal===
		+	Langmuir Monolayers of sweet orange essential oil, the phospholipids dipalmitoylphosphatidylcholine (DPPC), dipalmitoylphosphatidylglycerol (DPPG) and E.coli lipid extract were used to investigate the antibacterial properties of essential oils. The Langmuir Monolayer technique is a useful one for the formation of model cell membranes by allowing analysis of the interactions between the molecules and their organization capabilities. Monolayers using the sweet orange oil as a subphase with DPPC added were found to be more fluid, and to be less stable, as indicated by a low surface pressure at low molecular areas when compared to monolayers with ultra pure water as the subphase. Similarly, monolayers using the sweet orange oil as a subphase with the E. coli lipid extract added were found to be more fluid, and to be less stable, as indicated by a low surface pressure at low molecular areas when compared to monolayers with ultra pure water as the subphase. These results were also found with the trials of DPPG. Further investigations will involve using a simpler gram-negative model, such as 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS), since E. coli is a more complex gram-negative model, and observing those results in the orange oil, changing the concentration of the oil in the subphase and using different essential oils as subphases.

	===Instruments to be used===		===Instruments to be used===

@@ Line 11: / Line 11: @@
 ==Proposed Research Project==
 ===Enter Project Title here===
 ===General Information===